Lys280
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.1.1
Powered by Cell Signaling Technology
Home > Ubiquitylation Site Page: > Lys280  -  YAP1 (human)

Site Information
IsQsAPVkQPPPLAP   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 964556212

In vivo Characterization
Methods used to characterize site in vivo:
flow cytometry ( 1 ) , immunoprecipitation ( 1 , 2 ) , mass spectrometry ( 2 , 3 ) , mutation of modification site ( 2 ) , western blotting ( 1 , 2 )
Disease tissue studied:
gastric cancer ( 1 , 2 ) , gastric carcinoma ( 1 , 2 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on YAP1:
protein degradation ( 1 , 2 )
Effects of modification on biological processes:
carcinogenesis, altered ( 1 ) , carcinogenesis, inhibited ( 2 ) , cell growth, inhibited ( 2 )

References 

1

Yan C, et al. (2022) OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene
36271031   Curated Info

2

Tang DE, et al. (2019) STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling. Cancer Sci 110, 3145-3156
31393050   Curated Info

3

Akimov V, et al. (2018) UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol 25, 631-640
29967540   Curated Info